| Entity Name: | RVL PHARMACEUTICALS, INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: | Foreign Profit |
| Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
| Date Filed: | 02 Jun 2020 (5 years ago) |
| Document Number: | F20000002496 |
| FEI/EIN Number |
453077918
Federal Employer Identification (FEI) Number assigned by the IRS. |
| Address: | 400 Crossing Blvd, Bridgewater, NJ, 08807, US |
| Mail Address: | 400 Crossing Blvd, Bridgewater, NJ, 08807, US |
| Place of Formation: | DELAWARE |
| Name | Role | Address |
|---|---|---|
| Markison Brian | President | 400 Crossing Blvd, Bridgewater, NJ, 08807 |
| Einhorn Andrew | Treasurer | 400 Crossing Blvd, Bridgewater, NJ, 08807 |
| Klein Christopher | Secretary | 400 Crossing Blvd, Bridgewater, NJ, 08807 |
| Kavulich Mark | Director | 400 Crossing Blvd, Bridgewater, NJ, 08807 |
| CORPORATION SERVICE COMPANY | Agent | - |
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| CHANGE OF MAILING ADDRESS | 2024-02-09 | 400 Crossing Blvd, Bridgewater, NJ 08807 | - |
| CHANGE OF PRINCIPAL ADDRESS | 2021-04-06 | 400 Crossing Blvd, Bridgewater, NJ 08807 | - |
| Name | Date |
|---|---|
| ANNUAL REPORT | 2025-01-16 |
| ANNUAL REPORT | 2024-02-09 |
| ANNUAL REPORT | 2023-03-12 |
| ANNUAL REPORT | 2022-04-21 |
| ANNUAL REPORT | 2021-04-06 |
| Foreign Profit | 2020-06-02 |
Date of last update: 02 Apr 2025
Sources: Florida Department of State
